The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

Page 37 of 100

The 2018 Revised FDA Guidance for Early Alzheimer’s Disease: Establishing the Meaningfulness of Treatment Effects

The present report reviews the revised 2018 FDA guidance for early AD, with an emphasis on meaningfulness of clinical outcome assessments (COAs). A radical shift is evident in the importance given to establishing the meaningfulness of COAs in the 2018… Continue Reading →

Implementing a memory clinic model to facilitate recruitment into early phase clinical trials for mild cognitive impairment and alzheimer’s disease

 Our objective was to significantly facilitate recruitment into AD clinical trials by providing resources and education to patients, their treating physicians, and caregivers in the community. Park, C. Kouhanim, S. Lee, Z. Mendoza, K. Patrick, L. Gertsik, C. Aguilar, D…. Continue Reading →

Senolytics: The Modern Snake Oil?

Snake oil originally was a Chinese medication rich in omega-3 fatty acids which was made from de Chinese water snake. It was believed to decrease the pain of arthritis. The Hopi medicine men had used rattlesnake oil as an anti-inflammatory…. Continue Reading →

« Older posts Newer posts »

© 2025 Aging-news